Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Dream powder put to the test: will it beat a placebo for better sleep?

NCT ID NCT07183735

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested a powdered sleep supplement called BEAM Dream Powder in 40 adults who had trouble sleeping. For two weeks, participants took a placebo, then switched to the real powder for four weeks. Researchers used sleep questionnaires and Fitbit trackers to see if the powder improved sleep quality, restfulness, and energy levels.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
BEAM Dream Powder (dietary supplement)
What this could lead to
If it works, this could point toward a natural supplement to help people with mild sleep issues fall asleep and feel more rested.
What could go wrong
This is a small, early-stage trial with only 40 people. The results may not apply to everyone, and the supplement might not work better than a placebo.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

40 people

The number who actually took part.

Started

Jul 2024

Finished

Oct 2024

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male or female * 18+ years old * Self-reported issues with sleeping, falling asleep, or staying asleep. * Willing to discontinue any supplements, medications, herbal remedies, or melatonin products used to assist with sleep for the study duration. * Willing to avoid introducing any other supplements, medications, herbal remedies, or melatonin products used to assist with sleep for the duration of this trial. * Willing to maintain their standard sleep pattern and activity level for the duration of the study. * Be generally healthy and not live with any uncontrolled chronic disease. Exclusion Criteria: * Diagnosed with any chronic sleep condition, including but not limited to insomnia, narcolepsy, or sleep apnea. * Women who are pregnant, breastfeeding, or trying to conceive. * Anyone unwilling or unable to follow the study protocol. * Any pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders. * Is currently undergoing, or planning to undergo, any significant medical procedures during the study period. * Has undergone any surgeries or invasive treatments in the last six months. * A history of severe allergic reactions, including but not limited to any of the product's ingredients. * Anyone with a nut allergy. * Heavy drinkers. A heavy drinker is considered to be a woman who drinks 8 or more alcoholic drinks per week or a man who drinks 15 or more alcoholic drinks per week. * Anyone who uses illicit drugs. * Use any prescription medication, over-the-counter, or herbal remedies that can affect sleep. * Have a job that involves working the third or night shifts.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Sleep are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Citruslabs

    Las Vegas, Nevada, 89118, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.